Programme
| 08:00 – 15:00 | Pre-congress satellite meetings (see satellite meetings programme for details) |
| 12:00 – 19:00 | Registration Open (Registration Foyer) |
| 16:30 – 18:30 | Opening Ceremony (Ballroom, Level 1) 16:30 – 17:15 Opening Ceremony 17:15 – 17:25 Welcome Address (Raj Ramesar & Charles Rotimi, Co-Chairs of the Local Organising Committee) 17:25 – 17:35 Programme Introduction (Michele Ramsay, Chair of International Scientific Programme Committee) 17:35 – 18:20 Opening Address: “The Rise of Genomics in Africa” (Francis Collins, Former director, National Institutes of Health, USA) 18:20 – 18:30 Acknowledgements & Declare Congress Open (Raj Ramesar & Charles Rotimi) |
| 18:30 – 20:00 | Welcome Reception and Official Opening of Exhibition (Exhibition Hall 1 & 2) |
| 07:30 – 17:00 | Registration (Registration Foyer – Ground Level) | |||
| 09:00 – 16:00 | Exhibition (Hall 1 & 2 – Ground Level) | |||
| 07:30 – 08:45 | Meet the Professor / Meet the Expert / Workshops / Focus Groups / Breakfast Symposia Non Profit Organisations, Academic Institutions and Individuals applications (closing date: 30 November 2022: www.ichg2023.com/workshops-satellite-meetings-2) Sponsor and Exhibitor Applications (apply for a workshop / symposium sponsorship: www.ichg2023.com/sponsorship) |
|||
| 09:00 – 10:30 | Plenary 1 – Genomics and anthropology – insights on the peopling of Africa Venue: Ballroom (Level 1) Chairs: TBC |
|||
| 09:00 – 09:45 | The genetic history of Africa based on modern and ancient DNA ” – Carina Schlebusch, Sweden | |||
| 09:00 – 10:30 | “Academic and Social Consequences of Past Classifications of African Peoples” – Shomarka Keita, USA | |||
| 10:30 – 11:00 | Tea / Coffee Break | |||
| INVITED SESSIONS | ||||
| 11:00 – 12:30 | Session 1 – Genetic and Epigenetic Links Between Early Life and Later Life Health Outcomes Chair: Fasil Tekola-Ayele, USA (Venue: Ballroom East, Level 1) |
Session 2 – Global Perspectives on Return of Individual Research Results to Participants Chair: Ciara Staunton, Italy (Venue: Ballroom West, Level 1) |
Session 3 – Hemoglobinopathies: Challenges and Perspectives Chair: Martine de Rycke, Belgium (Venue: Meeting Block 1.4, Level 1) |
Session 4 – Vascular Anomalies: from Somatic Mutations towards Targeted Therapies Chair: Miikka Vikkula, Belgium (Venue: Meeting Block 1.6, Level 1) |
| Genetic and epigenetic regulation of fetal growth and links with adult cardiometabolic diseases: Fasil Tekola-Ayele, USA | Return of Results in a Healthy Cohort: The CHRIS Policy: Deborah Mascalzoni, Sweden/Italy | Perspectives in Genomics and Sickle Cell Disease Care in Africa: Ambroise Wonkam, USA/South Africa | Vascular Malformations: Genetic Discoveries on Pathophysiology: Miikka Vikkula, Belgium | |
| Genetic links between birthweight and type 2 diabetes in adulthood:Rachel Freathy, USA | Ethical Framework of the Hong Kong Genome Project on Return of Individual Research Results as Benefit Sharing: Calvin Ho, China | Hemoglobinopathies: Molecular genetics, diagnostic applications, challenges and future perspectives: Jan Traeger-Synodinos, Greece | Vascular Malformations: Lessons Learned from Preclinical Models: Taija Mäkinen, Sweden | |
| Genetic and epigenetic modifiers and mediators of perinatal environmental exposures and offspring cardiovascular health: Daniel Enquobahrie, USA | Communitarian Ethics and the Return of Genetic Results in Africa: Nchangwi Syntia Munung, South Africa | Preimplantation Genetic Testing for hemoglobinopathies and HLA typing: Martine De Rycke, Belgium | Vascular Malformations: Towards Precision Therapies: Laurence M. Boon, Belgium | |
| Using electronic health records to identify pleiotropy and shared genetic architectures of complex diseases: Tesfaye Mersha, USA | ||||
| Session 5 – The Contribution of African Genomics Research to Innovation in Psychiatry Chairs: Shareefa Dalvie, South Africa & Nastassja Koen, South Africa (Venue: Meeting Block 2.41-2.43, Level 2) |
Session 6 -The future of Genomics (ClinGen and ClinVar) Chair: (Venue: Meeting Block 2.44 – 2.46, Level 2) |
Session 7 – Cancer Genetics Chair: Raj Ramesar, South Africa (Venue: Meeting Block 2.61-2.63, Level 2) |
Session 8 – Host Genomics / Infectious Diseases Chair: (Venue: Meeting Block 2.64 – 2.66, Level 2) |
|
| An overview of NeuroGAP, including the rationale for launching the initiative and primary findings from this large-scale African genomic study: Lukoye Atwoli, Kenya | GWAS of Cancers in African Populations: Chris Mathew, South Africa/UK | |||
| Lessons learned in implementing the neuropsychiatric genetics capacity building program, GINGER: Kristianna Post, USA | Genomic Landscape of African Cancers: Sandeep Dave, USA | |||
| Population genomic resources to empower the PUMAS Project: Lerato Majara, South Africa | Cancer Genomics as a measure of Genetic Services in a Developing Country: Raj Ramesar, South Africa | |||
| 12:30 – 14:00 | Lunch Break | |||
| 13:00 – 14:00 | Lunch Symposia / Workshops | |||
| Lunchtime Symposium 1 | Lunchtime Symposium 2 | Lunchtime Symposium 3 | Lunchtime Symposium 4 | |
| Workshops / Focus Groups 3 | Workshops / Focus Groups 4 | Workshops / Focus Groups 5 | Workshops / Focus Groups 6 | |
| 14:00 – 15:00 | POSTER SESSION (Venue: Exhibition Hall – Hall 1 & 2, Ground Level) |
|||
| 15:00 – 15:30 | Tea / Coffee Break | |||
| 15:30 – 16:00 | Invited Keynote Speakers | |||
| Keynote 1 TBD, Kym Boycott, Canada |
Keynote 2 The genetics of major depression in diverse populations: Karoline Kuchenbaecker, UK |
Keynote 3 Ethical challenges of cutting-edge technologies: Ursula Matte, Brazil |
Keynote 4 Genomes and Genomics of Breast Cancers in Asian Patients, Soo-Hwang Teo, Malaysia |
|
| Keynote 5 Leveraging multi-omics for understanding mechanisms of hypertension: Patricia Munroe, UK |
Keynote 6 TBD, Cathy Wicklund, UK |
Keynote 7 New therapies for skeletal dysplasia (dwarfism): Ravi Savarinrayan, Australia |
Keynote 8 Connecting Population Genetics to Human Diseases: Special Referecne to Asia and the Indian Subcontinent, Analabha Basu, India |
|
| 16:00 – 17:30 | ORAL PRESENTATIONS | |||
| Oral Presentations 1 15:30 – 16:00 Invited Keynote 1 16:00 – 16:15 OP1 16:15 – 16:30 OP2 16:30 – 16:45 OP3 16:45 – 17:00 OP4 17:00 – 17:15 OP5 17:15 – 17:30 OP6 |
Oral Presentations 2 15:30 – 16:00 Invited Keynote 2 16:00 – 16:15 OP7 16:15 – 16:30 OP8 16:30 – 16:45 OP9 16:45 – 17:00 OP10 17:00 – 17:15 OP11 17:15 – 17:30 OP12 |
Oral Presentations 3 15:30 – 16:00 Invited Keynote 3 16:00 – 16:15 OP13 16:15 – 16:30 OP14 16:30 – 16:45 OP15 16:45 – 17:00 OP16 17:00 – 17:15 OP17 17:15 – 17:30 OP18 |
Oral Presentations 4 15:30 – 16:00 Invited Keynote 4 16:00 – 16:15 OP19 16:15 – 16:30 OP20 16:30 – 16:45 OP21 16:45 – 17:00 OP22 17:00 – 17:15 OP23 17:15 – 17:30 OP24 |
|
| Oral Presentations 5 15:30 – 16:00 Invited Keynote 5 16:00 – 16:15 OP25 16:15 – 16:30 OP26 16:30 – 16:45 OP27 16:45 – 17:00 OP28 17:00 – 17:15 OP29 17:15 – 17:30 OP30 |
Oral Presentations 6 15:30 – 16:00 Invited Keynote 6 16:00 – 16:15 OP31 16:15 – 16:30 OP32 16:30 – 16:45 OP33 16:45 – 17:00 OP34 17:00 – 17:15 OP35 17:15 – 17:30 OP36 |
Oral Presentations 7 15:30 – 16:00 Invited Keynote 6 16:00 – 16:15 OP37 16:15 – 16:30 OP38 16:30 – 16:45 OP39 16:45 – 17:00 OP40 17:00 – 17:15 OP41 17:15 – 17:30 OP42 |
Oral Presentations 8 15:30 – 16:00 Invited Keynote 8 16:00 – 16:15 OP43 16:15 – 16:30 OP44 16:30 – 16:45 OP45 16:45 – 17:00 OP46 17:00 – 17:15 OP47 17:15 – 17:30 OP48 |
|
| 18:00 – 19:30 | Meet the Professor / Meet the Expert / Workshops / Focus Groups / Dinner Symposia Non Profit Organisations, Academic Institutions and Individuals applications (closing date: 30 November 2022): www.ichg2023.com/workshops-satellite-meetings-2) Sponsor and Exhibitor Applications (apply for a workshop / symposium sponsorship: www.ichg2023.com/sponsorship) |
|||
| 19:30 – late | President’s Dinner (by invitation only) | |||
| 07:30 – 17:00 | Registration open (entrance to Hall 1, Ground Level) | ||||||||
| 09:00 – 16:00 | Exhibition open (Hall 1 & 2, Ground Level) | ||||||||
| 07:30 – 08:45 | Meet the Professor / Meet the Expert / Workshops / Focus Groups / Breakfast Symposia Non Profit Organisations, Academic Institutions and Individuals applications (closing date: 30 November 2022): ww.ichg2023.com/workshops-satellite-meetings-2 Sponsor and Exhibitor Applications (apply for a workshop / symposium sponsorship: www.ichg2023.com/sponsorship) |
||||||||
| 09:00 – 10:30 | Plenary 2 – Translational Genomics and Implementation Science Chairs: TBC Venue: Ballroom, Level 1 |
||||||||
| 09:00 – 09:45 | “Non-Invasive Prenatal Testing as an Archtype of Translational Genomics” – Dennis Lo, Hong Kong | ||||||||
| 09:45 – 10:30 | “Genomics and the Future of Medicine” – Mayana Zatz, Brazil | ||||||||
| 10:30 – 11:00 | Tea / Coffee Break | ||||||||
| 11:00 – 12:30 | INVITED SESSIONS | ||||||||
| Session 9 – Diversity for the Future of Precision Medicine & Health Population Screening Chair: Vicky Nembaware, South Africa (Venue: Ballroom East, Level 1) |
Session 10 – Global Initiatives in Genomic Medicine Workforce Development: Ensuring Best Practice in Genomic Education Chairs: Tina-Marie Wessels, South Africa & Sylvia Metcalfe, Australia (Venue: Ballroom West, Level 1) |
Session 11 – Therapeutic Approaches to Genetic Disorders – Before, During and After Chair: Shahida Moosa, South Africa & Careni Spencer, South Africa (Venue: Meeting Block 1.4, Level 1) |
Session 12 – Advances in Genetics and Gene Directed Therapies for Inherited Retinal Diseases Chair: Alison Hardcastle, UK (Venue: Meeting Block 1.6, Level1) |
||||||
| Lack of Diversity Remains an Unsolved Problem for Precision Medicine but Hopefully Not for Long: Janina Jeff, USA | Ensuring Best Practice in Genomics Education and Evaluation: The Australian Genomics Workforce and Education Research Program: Amy Nisselle, Australia | Novel Therapies: Achondroplasia as a Model: Melita Irving, UK | Advances in Defining the Inherited Retinal Disease Genome: Alison Hardcastle, UK | ||||||
| Novel and Known Genes associated with Cardiovascular Disease Risks in African Populations: Palwendé Boua, Burkina Faso | Supporting The Implementation of a National Genomics Medicine Service In England: Michelle Bishop, UK | Genetic Biobanks, Registries, Patient Organisations: Towards Therapies for FOP: Luca Sangiorgi, Italy | Modelling Inherited Retinal Diseases with Stem Cells: Michael Cheetham, UK | ||||||
| Importance of Building up Local Infrastructure to Provide Whole-Genome Sequencing for Rapid Response, for Critically Ill Patients: Ahmad Abou Tayoun, United Arab Emirates | The African Genomic Medicine Training (AGMT) Initiative: Nicola Mulder, South Africa | New Therapeutic Interventions in Neuromuscular Diseases: Matthew Wood, UK | Genetic Therapies for Inherited Retinal Diseases: From Fiction to Fact: Bart Leroy, Belgium | ||||||
| Educating the Genomics Community on Updated ACMG/Clingen Technical Standards for Interpretation and Reporting of Constitutional Copy Number Variants: Erin Rooney Riggs, USA | |||||||||
| Panel discussion with all presenters: Lessons Learned from International Workforce Development Initiatives: Looking Back to Move Forward | |||||||||
| Session 13 – Methodology and Considerations for Analyses in Diverse Populations Chair: Marika Kaakinen, UK & Krista Fischer, Estonia (Venue: Meeting Block 2.41 – 2.43, Level 2) |
Session 14 – The Future of Genomics – (Topic TBC) Chair: TBC (Venue: Meeting Block 2.64 – 2.66, Level 2) |
Session 15 – Multi-Omics Chair: Ayse Demirkan, UK (Venue: Meeting Block 2.61 – 2.63, Level 2) |
Session 16 – Sustainable Development Goals (SDG 2030) For Genetic and Genomic Disorders Chair: Meow-Keong Thong, Malaysia (Venue: Meeting Block 2.64 – 2.66, Level 2) |
||||||
| The Power of Diverse Populations for Discovery and Translation of Genome-Wide Association Studies: Andrew Morris, UK | Pharmacogenetics in African -American Populations: Minoli Perera, USA | Achieving Sustainable Development Goals for Congenital Disorders: Challenges and Opportunities: Meow Keong Thong, Malaysia | |||||||
| Diversity in Genetic Studies aids Locus Discovery, Fine-Mapping, Gene Prioritisation, and Causal Inference: Karoline Kuchenbaecker, UK | Single Cell Transcriptomics: Peter Kharchenko, USA | Newborn Screening: Way Forward for SDGS From Global Perspective: Carmencita Padilla, Philippines | |||||||
| Incorporating Local Ancestry in the Construction of Polygenic Risk Scores: Yun Li, USA | Gut microbiome: Alexandra Zhernakova, Netherlands | Next Generation Sequencing Technology: Levelling the Playing Field For SDGS in Genomic Medicine: Lai Poh San, Singapore | |||||||
| 12:30 – 14:00 | Lunch Break | ||||||||
| 13:00 – 14:00 | LUNCHTIME SYMPOSIA / WORKSHOPS | ||||||||
| 13:00 – 14:00 | Lunchtime Symposium 5 | Lunchtime Symposium 6 | Lunchtime Symposium 7 | Lunchtime Symposium 8 | |||||
| Workshop / Focus Group 9 | Workshop / Focus Group 10 | Workshop / Focus Group 11 | Workshop / Focus Group 12 | ||||||
| 14:00 – 15:00 | POSTER SESSION (Venue: Exhibition Hall – Hall 1 & 2, Ground Level) |
||||||||
| 15:00 – 15:30 | Tea / Coffee Break | ||||||||
| 15:30 – 16:00 | Invited Keynote Speakers | ||||||||
| Keynote 9 Challenges in biobank-based personalized risk prediction and communication: Krista Fischer, Estonia |
Keynote 10 How digital tools are changing equity & quality of genomic medicine: Evidence, preferences & policy: Yvonne Bombard, Canada |
Keynote 11 Consanguinity and gentic diseases in North Africa: are we ready for precision medicine? : Sonia Abdelhak, Tunisia |
Keynote 12 Populations genetics and evolution: A Mexican cohort, Mashaal Sohail, Mexico |
||||||
| Keynote 13 Using Zebrafish Larvae to Characterize Candidate Genes for Cardiometabolic Health: Marcel den Hoed, Sweden |
Keynote 14 Using Epigenomics to Understand Human Disease, John Greally, USA |
Keynote 15 New therapies for skeletal dysplasia (dwarfism): Ravi Savarinrayan, Australia |
Keynote 16 | ||||||
| 16:00 – 17:30 | ORAL PRESENTATIONS | ||||||||
| Oral Presentations 9 15:30 – 16:00 Invited Keynote 9 16:00 – 16:15 OP49 16:15 – 16:30 OP50 16:30 – 16:45 OP51 16:45 – 17:00 OP52 17:00 – 17:15 OP53 17:15 – 17:30 OP54 |
Oral Presentations 10 15:30 – 16:00 Invited Keynote 10 16:00 – 16:15 OP55 16:15 – 16:30 OP56 16:30 – 16:45 OP57 16:45 – 17:00 OP58 17:00 – 17:15 OP59 17:15 – 17:30 OP60 |
Oral Presentations 11 15:30 – 16:00 Invited Keynote 11 16:00 – 16:15 OP61 16:15 – 16:30 OP62 16:30 – 16:45 OP63 16:45 – 17:00 OP64 17:00 – 17:15 OP65 17:15 – 17:30 OP66 |
Oral Presentations 12 15:30 – 16:00 Invited Keynote 12 16:00 – 16:15 OP67 16:15 – 16:30 OP68 16:30 – 16:45 OP69 16:45 – 17:00 OP70 17:00 – 17:15 OP71 17:15 – 17:30 OP72 |
||||||
| Oral Presentations 13 15:30 – 16:00 Invited Keynote 13 16:00 – 16:15 OP73 16:15 – 16:30 OP74 16:30 – 16:45 OP75 16:45 – 17:00 OP76 17:00 – 17:15 OP77 17:15 – 17:30 OP78 |
Oral Presentations 14 15:30 – 16:00 Invited Keynote 14 16:00 – 16:15 OP79 16:15 – 16:30 OP80 16:30 – 16:45 OP81 16:45 – 17:00 OP82 17:00 – 17:15 OP83 17:15 – 17:30 OP84 |
Oral Presentations 15 15:30 – 16:00 Invited Keynote 15 16:00 – 16:15 OP85 16:15 – 16:30 OP86 16:30 – 16:45 OP87 16:45 – 17:00 OP88 17:00 – 17:15 OP89 17:15 – 17:30 OP90 |
Oral Presentations 16 15:30 – 16:00 Invited Keynote 16 16:00 – 16:15 OP91 16:15 – 16:30 OP92 16:30 – 16:45 OP93 16:45 – 17:00 OP94 17:00 – 17:15 OP95 17:15 – 17:30 OP96 |
||||||
| 18:00 – 19:30 | Meet the Professor / Meet the Expert / Workshops / Focus Groups / Dinner Symposia Non Profit Organisations, Academic Institutions and Individuals applications (closing date: 30 November 2022): hwww.ichg2023.com/workshops-satellite-meetings-2) Sponsor and Exhibitor Applications (apply for a workshop / symposium sponsorship: www.ichg2023.com/sponsorship) |
||||||||
| Evening at leisure | |||||||||
| 07:30 – 17:00 | Registration open (entrance to Hall 1, Ground Level) | |||
| 09:00 – 16:00 | Exhibition open (Hall 1 & 2, Ground Level) | |||
| 07:30 – 08:45 | Meet the Professor / Meet the Expert / Workshops / Focus Groups / Breakfast Symposia Non Profit Organisations, Academic Institutions and Individuals applications (closing date: 30 November 2022): hwww.ichg2023.com/workshops-satellite-meetings-2) Sponsor and Exhibitor Applications (apply for a workshop / symposium sponsorship: www.ichg2023.com/sponsorship) |
|||
| 09:00 – 10:30 | Plenary 3 – Mechanisms of Disease: The Functional Genome Chairs: TBC Venue: Ballroom, Level 1 |
|||
| 09:00 – 09:45 | “Autozygome as a Tool to Enhance the Clinical Annotation of the Human Genome” – Fowzan Alkuraya, Saudi Arabia | |||
| 09:45 – 10:30 | “Pathways to Disease and Pleiotropy (Multi-Omics)” – Nicole Soranzo, UK | |||
| 10:30 – 11:00 | Tea / Coffee Break | |||
| 11:00 – 12:30 | INVITED SESSIONS | |||
| Session 17 – Predicting Phenotypes for Polygenic Traits in Diverse Populations Chair: Ricardo Vrdugo, Chile (Venue: Ballroom East, Level 1) |
Session 18 – The Role of Patient Advocacy – The Example of Rare Disease Chairs: Helen Malherbe, South Africa & Mariela Larrandaburu, Uruguay (Venue: Ballroom West, Level 1) |
Session 19 – Long read sequencing technologies to dissect various diseases Chair: Naomichi Matsumoto, Japan (Venue: Meeting Block 1.4, Level 1) |
Session 20 – Inherited Errors of Immune Deficiency: Primary Immune Deficits Chairs: Craig Kinnear, South Africa (Venue: Meeting Block 1.6, Level 1) |
|
| Assessment of the Predictive Power of Polygenic Risk Scores in an Admixed Population from South America for Nine Common Diseases: Ricardo A. Verdugo, Chile | Orphanet and hospital-based programs as tools to address undiagnosed and rare diseases: Francesc Palau, Spain | Strategy solving human repeat diseases: Naomichi Matsumoto, Japan | NGS and Infectious Diseases – A Journey of Discoveries: Anna Puel, France | |
| Developing Effective Polygenic Risk Scores for Cancer for Latin American Populations: Luis Carvajal-Carmona, USA | The importance of collaboration between the lay support communities and research groups for rare disease research: Colleen Aldous, South Africa | A catalogue of human structural variations: Shiichi Morishita, Japan | WES and WGS in South Africa for Inherited Errors of Immunity – Facts, Fallacies and VUS: Brigitte Glanzmann, South Africa | |
| Developing Effective Polygenic Risk Scores for Multi-Ethnic Populations in Africa: Eimear Kenny, USA | The strength of the associative movement in rare diseases in Ibero-America: ENSERIO LATAM study, future challenges: Juan Carrion, Spain | Genomic answers for children: dynamic analysis of >1000 pediatric rare: Ornit Chiba-Falek, USA |
||
| The Power of Advocacy: Kelly du Plessis, South Africa | ||||
| Session 21 – Overcoming Barriers to Capturing Diversity in Global Genetics Research Chair: Athena Starlard-Davenport, USA (Venue: Meeting Block 2.61 – 2.63, Level 2) |
Session 22 – An Opportunity to Shape the Global Landscape and Develop a Common Language and Standards for Human Genetics and Genomics Chair: Michele Ramsay, South Africa (Venue: Meeting Block 2.44 – 2.46, Level 2) |
Session 23 – Artificial Intelligence to Enable Clinical Genomics Around the World Chair: Francisco De La Vega, USA (Venue: Meeting Block 2.61 – 2.63, Level 2) |
Session 24 – Global Globin Network (GGN): (Public Health Issues in Haemoglobinopathies) Chair: Zilfalil Bin Alwi, Malaysia (Venue: Meeting Block 2.64 – 2.66, Level 2) |
|
| Diversity in Genetics and Genomic Studies: Adebowale A. Adeyemo, USA | HUGO, The Human Genome Organization, Working to Ensure that the Human Genome Includes and Benefits All: Ada Hamosh, USA | Population Screening in the Genomics Era: Zilfalil Alwi, Malaysia | ||
| Beyond Inclusion: Empowering Indigenous Genomic Data Equity in Health: Krystal Tsosie, USA | Developing Technical Standards and Policy Frameworks to Accelerate Responsible Sharing of Genomic and Related Health Data: Peter C Goodhand, Canada | |||
| Building capacity in African Genomics: perspectives from an early career researcher: Lerato Majara, USA | Realizing the Full Potential of Longitudinal Populations Studies and Health Systems to Advance Global Health: Geoffrey S Ginsburg, USA | |||
| 12:30 – 14:00 | Lunch Break | |||
| 13:00 – 14:00 | LUNCHTIME SYMPOSIA / WORKSHOPS | |||
| 13:00 – 14:00 | Lunchtime Symposium 5 | Lunchtime Symposium 6 | Lunchtime Symposium 7 | Lunchtime Symposium 8 |
| 13:00 – 14:00 | Workshop / Focus Group 9 | Workshop / Focus Group 10 | Workshop / Focus Group 11 | Workshop / Focus Group 12 |
| 14:00 – 15:00 | POSTER SESSION (Venue: Exhibition Hall – Hall 1 & 2, Ground Level) |
|||
| 15:00 – 15:30 | Tea / Coffee Break | |||
| 15:30 – 16:00 | Invited Keynote Speakers | |||
| Keynote 17 TBD, Bruno Reversade: Singapore |
Keynote 18 Genomics Equity for Health in Latin America, Claudia Gonzaga-Jauregui, Mexico |
Keynote 19 TBD |
Keynote 20 TBD |
|
| Keynote 21 TBD |
Keynote 22 TBD |
Keynote 23 TBD |
Keynote 24 TBD |
|
| 13:00 – 14:00 | ORAL PRESENTATIONS | |||
| 15:30 – 17:30 | Oral Presentations 17 15:30 – 16:00 Invited Keynote 17 16:00 – 16:15 OP97 16:15 – 16:30 OP98 16:30 – 16:45 OP99 16:45 – 17:00 OP100 17:00 – 17:15 OP101 17:15 – 17:30 OP102 |
Oral Presentations 18 15:30 – 16:00 Invited Keynote 18 16:00 – 16:15 OP103 16:15 – 16:30 OP104 16:30 – 16:45 OP105 16:45 – 17:00 OP106 17:00 – 17:15 OP107 17:15 – 17:30 OP108 |
Oral Presentations 19 15:30 – 16:00 Invited Keynote 19 16:00 – 16:15 OP109 16:15 – 16:30 OP110 16:30 – 16:45 OP111 16:45 – 17:00 OP112 17:00 – 17:15 OP113 17:15 – 17:30 OP114 |
Oral Presentations 20 15:30 – 16:00 Invited Keynote 20 16:00 – 16:15 OP115 16:15 – 16:30 OP116 16:30 – 16:45 OP117 16:45 – 17:00 OP118 17:00 – 17:15 OP119 17:15 – 17:30 OP120 |
| Oral Presentations 21 15:30 – 16:00 Invited Keynote 21 16:00 – 16:15 OP121 16:15 – 16:30 OP122 16:30 – 16:45 OP123 16:45 – 17:00 OP124 17:00 – 17:15 OP125 17:15 – 17:30 OP126 |
Oral Presentations 22 15:30 – 16:00 Invited Keynote 22 16:00 – 16:15 OP127 16:15 – 16:30 OP128 16:30 – 16:45 OP129 16:45 – 17:00 OP130 17:00 – 17:15 OP131 17:15 – 17:30 OP132 |
Oral Presentations 23 15:30 – 16:00 Invited Keynote 23 16:00 – 16:15 OP133 16:15 – 16:30 OP134 16:30 – 16:45 OP135 16:45 – 17:00 OP136 17:00 – 17:15 OP137 17:15 – 17:30 OP138 |
Oral Presentations 24 15:30 – 16:00 Invited Keynote 24 16:00 – 16:15 OP139 16:15 – 16:30 OP140 16:30 – 16:45 OP141 16:45 – 17:00 OP142 17:00 – 17:15 OP143 17:15 – 17:30 OP144 |
|
| 18:00 – 19:30 | Meet the Professor / Meet the Expert / Workshops / Focus Groups / Dinner Symposia Non Profit Organisations, Academic Institutions and Individuals applications (closing date: 30 November 2022): hwww.ichg2023.com/workshops-satellite-meetings-2) Sponsor and Exhibitor Applications (apply for a workshop / symposium sponsorship: www.ichg2023.com/sponsorship |
|||
| 18h30 – 22h30 | Conference Dinner at GOLD Restaurant (A true African experience) Ticketed event: R1,150 per person Limited to 350 places |
|||
| 07:30 – 17:00 | Registration open (entrance to Hall 1, Ground Level) | |||
| 09:00 – 16:00 | Exhibition open (Hall 1 & 2, Ground Level) | |||
| 07:30 – 08:45 | Meet the Professor / Meet the Expert / Workshops / Focus Groups / Breakfast Symposia Non Profit Organisations, Academic Institutions and Individuals applications (closing date: 30 November 2022): www.ichg2023.com/workshops-satellite-meetings-2) Sponsor and Exhibitor Applications (apply for a workshop / symposium sponsorship: www.ichg2023.com/sponsorship) |
|||
| 09:00 – 10:30 | Plenary 4 – The future of genetics and genomics Chairs: TBC Venue: Ballroom, Level 1 |
|||
| 09:00 – 09:45 | “Interpreting Genomic Variation in Cancer ” – Mathieu Lupien, Canada | |||
| 09:45 – 10:30 | “The Next Frontier in Personal Genomics” – Eric Topol, USA | |||
| 10:30 – 11:00 | Tea / Coffee Break | |||
| 11:00 – 12:30 | INVITED SESSIONS | |||
| Session 25 – International Genetic Epidemiology Society: Genomics for Global Precision Medicine Chair: Eleftheria Zeggini, Germany (Venue: Ballroom East, Level 1) |
Session 26 – Privacy, consent and data sharing in the international genetics community Chairs: Francesca Forzano, UK & Kelly Ormond, Switzerland/USA (Venue: Ballroom West, Level 1) |
Session 27 – Resolving Unresolved Neurodevelopmental Disabilities Chairs: Jozef Gecz, Australia & Heather Mefford, USA (Venue: Meeting Block 1.4, Level 1) |
Session 28 – Southern African Population Structure, Admixture and Adaptation Chair: Carina Schlebusch, Sweden (Venue: Meeting Block 1.6, Level 1) |
|
| Genomics of Metabolic Disease in Diverse Populations: Inês Barroso, UK | the South African Protection of Personal Information Act (POPIA) and the H3Africa perspective: Michele Ramsay, South Africa | Current day clinical genetics in neurodevelopmental disorderss: Tjitske Kleefstra, Netherlands. | The Complexity of Population Movements and Admixture Patterns during the Bantu Expansion: Sandra Beleza, UK | |
| Polygenic Risk Scores across Global Populations: Andrew Morris, UK | LatinGen initiative and BipMed (Brazilian Initiative on Precision Medicine): Iscia Lopes-Cendes, Brazil | DNA Methylation Episignatures as Clinical Diagnostic Biomarkers for Rare Diseases: Bekim Sadikovic, Canada | Khoesan Gene Flow in Southern Africa and Implications for Genetic Studies: Ananyo Choudhury, South Africa | |
| Using Genomics for the Treatment and Prevention of Breast Cancer: Olufunmilayo Olopade, USA | Research and Policy initiatives in Australia regarding genomic data sharing: Ainsley Newson, Australia | Rare and Common Variant Contributions to NDD: Hilary Martin, UK | The Evolution of Skin Pigmentation in Southern Africa: Brenna Henn, USA | |
| Session 29 – Polygenic Risk Scores In Practice: Laboratory, Clinical, And Ethical Perspectives Chair: Jason Vassy, USA (Venue: Meeting Block 2.61 – 2.63, Level 2) |
Session 30 – Precision Molecular Cytogenetics: A Time to Sequence Chair: Richard Kwong Wai Choy, China (Venue: Meeting Block 2.44 – 2.46, Level 2) |
Session 31: Showcasing H3Africa research Chair: Zane Lombard, South Africa (Venue: Meeting Block 2.61 – 2.63, Level 2) |
Session 32 – Reproductive Carrier Screening – Meeting the Challenges Chair: Edwin Kirk, Australia (Venue: Meeting Block 2.64 – 2.66, Level 2) |
|
| Polygenic Risk Scores in the Clinical Laboratory: Matthew Lebo, USA | Mate-Pair Sequencing and the Road towards Comprehensive Identification and Interpretation of Pathogenic Structural Variation: Cynthia C Morton, USA | Meta-analysis of sub-Saharan African studies provides insights into genetic architecture of lipid traits: Ananyo Choudhury, South Africa | Ethical aspects of population-scale reproductive genetic carrier screening: Ainsley Newson, Australia | |
| Polygenic Risk Scores in Medical Practice: Jason Vassy, USA | Implementation Of Genome Sequencing: Experience in a Genetic Diagnostic Laboratory: Zirui (Elvis) Dong, China | HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria: Christian Happi, Nigeria | Turning the tide on autosomal recessive diseases: The double edged sword of consanguinity: Fowzan Alkuraya, Saudi Arabia | |
| Ethical Considerations of Polygenic Risk Scores in the Clinic: Anna C.F. Lewis, USA | Diagnostic Management of Apparently Balanced Structural Variants: Matthew Chau.USA | Leukocyte methylomic imprints of exposure to the genocide against the Tutsi in Rwanda: Leon Mutesa, Rwanda | Design, implementation and outcomes of The Australian Reproductive Genetic Carrier Screening Project (“Mackenzie’s Mission”) – screening > 9,000 couples for 1,281 genes to pave the way for a national screening program: Edwin Kirk: Edwin Kirk, Australia | |
| 12:30 – 13:30 | Closing Ceremony Chairs: TBC (Venue: Ballroom, Level 1) – Awards – Best Oral |
|||
